Psychedelic Medicine

Association

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

Excerpts from the publication

Summary
Psilocybin is a serotonergic psychedelic with untapped therapeutic potential. There are hints that the use of psychedelics can produce neural adaptations, although the extent and timescale of the impact in a mammalian brain are unknown. In this study, we used chronic two-photon microscopy to image longitudinally the apical dendritic spines of layer 5 pyramidal neurons in the mouse medial frontal cortex. We found that a single dose of psilocybin led to ∼10% increases in spine size and density, driven by an elevated spine formation rate. The structural remodeling occurred quickly within 24 h and was persistent 1 month later. Psilocybin also ameliorated stress-related behavioral deficit and elevated excitatory neurotransmission. Overall, the results demonstrate that psilocybin-evoked synaptic rewiring in the cortex is fast and enduring, potentially providing a structural trace for long-term integration of experiences and lasting beneficial actions

Read more

Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review